ArticleJournal of thoracic disease2021

Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction.

Colin A Hinkamp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.